Alberts, S R <br/><br/>
Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II study.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Apr 2003 
 - 580-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0923-7534 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdg170  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Deoxycytidine--administration & dosage<br/>Disease Progression<br/>Female<br/>Hemolytic-Uremic Syndrome--chemically induced<br/>Humans<br/>Infusions, Intravenous<br/>Male<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Organoplatinum Compounds--administration & dosage<br/>Oxaliplatin<br/>Pancreatic Neoplasms--drug therapy<br/>Survival<br/>Treatment Outcome<br/>Gemcitabine